Stem cell-focused oncology company Vor Biopharma made a series of appointments to its leadership team.
The company named Sadik Kassim, PhD, its chief technology officer, and hematological and gene engineering research specialist Tirtha Chakraborty, PhD, joined as vice president of research.
The appointments follow Vor's recent move to a new headquarters in Cambridge, Mass., and the recent appointment of Dr. Robert Ang as the company's new CEO and president.